Some 2,000 people have taken part in a ground-breaking trial to test an algorithm that can help doctors identify people at risk of developing atrial fibrillation (AF). The trial is evaluating an ...

UK digital health company RHYTHM AI has claimed FDA approval for a new version of its algorithm for mapping areas of the heart that are affected by atrial fibrillation (AFib) that will be rolled out ...

AliveCor has received an additional FDA 510(k) clearance, this time for an algorithm that allows its smartphone ECG to detect atrial fibrillation -- an abnormal heart rhythm that isn't always ...

The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency, reproducibility, and ...

Researchers have developed an AI tool that creates synthetic yet medically accurate models of fibrotic heart tissue (heart scarring), aiding treatment planning for atrial fibrillation (AF) patients.

DelveInsight's,“ Atrial Fibrillation Pipeline Insight, 2025 ” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Atrial Fibrillation pipeline landscape. It covers the ...

(MENAFN- GlobeNewsWire - Nasdaq) The atrial fibrillation market thrives on rising disease prevalence, technological advancements in AI and remote monitoring, and the need for innovative treatments.

A new Ottawa biotech startup is seeking to raise $4 million to produce groundbreaking treatments aimed at curing one of the most common heart rhythm disturbances. Incorporated in 2022, Rhythm ...